Global Category Research
Pubblicato il 27-08-2026 - Chiesi Group in Italia
Chiesi is an international research-focused biopharmaceutical group with 90 years' experience, operating in more than 30 countries, with its Headquarter in Parma, Italy. This is what drives us as we research, develop, and market innovative drugs across our main therapeutic areas. At Chiesi we are thinking generations ahead, driving sustainable innovation with purpose. As a Agevolazioni Corporation and a certified B Corp, we have embedded sustainability in our bylaws and continuously measure our impact.
We believe our differences make us stronger. Chiesi Corporate Functions
At Chiesi, the Corporate Functions serve as drive and support for the Group's business operations. Encompassing key areas such as Global Finance, Global Procurement, Global ICT, Global Human Resources, Global Legal, Compliance & IP, and Global Communications & Public Affairs, these functions ensure consistency, efficiency, and operational integrity.
Complementing these functions, the Transformation Office is responsible for ensuring the strategic alignment of the organization. It promotes an integrated, digital,
and customer‐centric approach, supporting growth, efficiency, and value creation in an increasingly data‐driven world. The Strategy, Sustainability & Growth Department is also part of the Corporate Functions. It includes areas such as Global Strategy, SV&S; and Business Development, Competitive Intelligence, and other key capabilities. You will join the Global R&D; Procurement organization at Chiesi Farmaceutici, acting as Global Category Lead for Research & Preclinical services.
The role is designed to ensure continuity, strategic leadership and operational excellence across critical external partnerships supporting early‐stage R&D; activities.
You will work in close business partnership with Global Research & Preclinical Development and GRD Preclinical stakeholders, contributing to the delivery of the R&D; pipeline through robust category strategies, effective supplier governance and value‐driven